Exemplar Genetics
Exemplar Genetics develops and supplies gene-edited minipig models of human disease, along with cloning, housing, characterization, and preclinical research services, for pharmaceutical, biotechnology, academic, and disease foundation clients.
- Company typePrivate
- Founded2007
- HeadquartersSioux Center, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Exemplar Genetics firmographics
Firmographics- Name
- Exemplar Genetics
- Legal name
- Exemplar Genetics, Inc.
- Website
- https://exemplargenetics.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Exemplar Genetics develops and supplies gene-edited minipig models of human disease, along with cloning, housing, characterization, and preclinical research services, for pharmaceutical, biotechnology, academic, and disease foundation clients.
- Ownership category
- akta.pro rank
Exemplar Genetics industry classification
Industry- Product category
- Preclinical Translational Disease Models
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Preclinical Development (Pharmacology, PK/PD, ADME, Toxicology) (HLAIALAC)
Keywords
Where Exemplar Genetics is headquartered
LocationHeadquarters
- HQ city
- Sioux Center
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Exemplar Genetics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Standard Minipig Models: Off-the-shelf gene-edited minipig models of human disease available for immediate purchase. Includes 20 currently available models across various indications including hypercholesterolemia, cardiomyopathy, cystic fibrosis, and cancer.
- Custom Model Development: End-to-end custom gene-edited minipig model development including gene engineering, minipig cloning, housing, characterization, and preclinical research services tailored to specific client specifications.
- Characterization Services: Broad range of model characterization capabilities to advance utility for mechanistic discovery and preclinical research applications.
- Housing Services: Biosecure, AAALAC-accredited housing facilities for chronic drug studies or longitudinal natural history studies, with almost 50,000 square feet of capacity.
- Preclinical Services: Comprehensive preclinical research services including dosing studies (small molecules, viral vectors, lipid nanoparticles), imaging (MRI, ECHO, fluoroscopy), and functional analysis (treadmill and gait analysis).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Standard Models - Off-the-shelf gene-edited minipig models |
| Other | Multi-year contract | Custom Models - Gene-edited minipig models designed to specifications |
| Other | Multi-year contract | Characterization Services |
| Other | Multi-year contract | Housing - Biosecure facilities |
| Other | Multi-year contract | Preclinical Services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Exemplar Genetics product offering
Product offeringCore offering
Exemplar Genetics develops and supplies gene-edited minipig models of human disease for preclinical research. It sells 20 off-the-shelf standard disease models and provides end-to-end custom model development, plus supporting services in characterization, biosecure housing, and preclinical testing (dosing, imaging, functional analysis) to pharmaceutical, biotech, academic, and foundation customers.
Product overview
Exemplar Genetics is a preclinical research services company offering a unified portfolio of gene-edited minipig models and associated services. The core offerings include Standard Models (20 off-the-shelf disease models) and Custom Models (client-specified gene-edited minipigs using SCNT cloning technology). These models are supported by Characterization Services, Housing (50,000 sq ft AAALAC-accredited facilities), and Preclinical Services (dosing/efficacy studies with MRI, ECHO, fluoroscopy, treadmill/gait analysis capabilities). The company operates on Yucatan minipig genetics and licensed Göttingen minipig genetics, providing end-to-end solutions from gene editing through preclinical research.
Differentiator
Problem solved
Functional benefit
Products and services
- Standard Models Off-the-shelf gene-edited minipig models of human disease commercially available for purchase, with 20 models spanning indications including hypercholesterolemia/atherosclerosis, cardiomyopathy, cardiac arrhythmia, Duchenne muscular dystrophy, cystic fibrosis, ataxia telangiectasia, Batten disease, cancer, neurofibromatosis type 1, and autosomal dominant polycystic kidney disease. Targeted at pharmaceutical, biotech, and academic preclinical researchers.
- Custom Models Gene-edited minipig models designed to client specifications using SCNT cloning technology, providing an end-to-end solution that includes gene engineering/editing, minipig cloning, housing, characterization, and preclinical research services. Targeted at clients requiring a specific disease model not available off the shelf.
- Characterization Services Comprehensive characterization capabilities for newly developed minipig models, working closely with clients to advance utility for mechanistic discovery and preclinical research applications. Targeted at researchers needing validated phenotypic and molecular characterization of their models.
- Housing Biosecure housing facilities with approximately 50,000 square feet of capacity, AAALAC International accredited, accommodating chronic drug studies or longitudinal natural history studies. Targeted at clients needing regulatory-grade animal housing for extended studies.
- Preclinical Services Preclinical research services including dosing and efficacy studies with small molecules, viral vectors, and lipid nanoparticles; on-site imaging (MRI, ECHO, fluoroscopy); and functional analysis (treadmill and gait analysis). Targeted at pharmaceutical and biotech clients seeking integrated preclinical support.
Quantifiable outcome
- 75+ publications in top-tier journals including Science, Nature, and Cell
- +1 more outcomes
Companies that use Exemplar Genetics
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Exemplar Genetics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Exemplar Genetics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Ellegaard Göttingen MinipigscoreExemplar has licensed access to Göttingen minipig genetics via agreement with Ellegaard Göttingen Minipigs. This provides clients an alternative genetic background option alongside Exemplar's proprietary Yucatan minipig herd when developing custom gene-edited minipig models.
Scale indicators5 records
Recent moves5 records
Expansion highlights4 records
Exemplar Genetics competitors and assessment
Company assessmentEmerging players
- Ozgene: Ozgene is a gene-editing CRO specializing in custom rodent and large animal model generation, with similar end-to-end model development services targeting pharma and academic researchers.
- Hera BioLabs: Hera BioLabs is a specialty CRO focused on gene-edited rat and other translational models, representing an emerging peer with overlapping gene-editing and preclinical service capabilities.
Broad incumbents
- Inotiv: Inotiv is a preclinical CRO providing research models and discovery, safety, and analytical services; its large-animal model and contract research segments overlap with Exemplar's preclinical and model offerings.
- Charles River Laboratories: Charles River is the largest preclinical CRO globally, offering a broad portfolio of research models and discovery and safety assessment services that directly overlap Exemplar's preclinical service offering, though at much larger scale and broader scope.
- Labcorp (Covance): Labcorp's Covance segment is a global CRO offering preclinical and clinical services, including nonclinical safety and translational research that competes with Exemplar's preclinical services portfolio at enterprise scale.
- The Jackson Laboratory: Jackson Laboratory is a major nonprofit provider of genetically defined research models and translational research services, with overlapping scientific credibility and catalog model offerings for the biomedical research community.
Direct peers
- Cyagen Biosciences: Cyagen is a CRO specializing in gene-edited animal models and cell line development, with overlapping gene-editing capabilities and custom model services used by pharma and academic researchers.
- Taconic Biosciences: Taconic is a leading provider of genetically engineered research animal models, primarily rodents, with a similar business model of catalog and custom model offerings to biomedical researchers.
- Sinclair Research: Sinclair Research is a contract research organization focused on minipig and swine preclinical studies, making it one of the closest direct comparables to Exemplar in large-animal CRO services for pharma and biotech clients.
- Marshall BioResources: Marshall BioResources is a specialty provider of purpose-bred large animal research models and related services, including minipigs, directly overlapping with Exemplar's minipig model and preclinical service offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Exemplar Genetics social profiles
Digital presenceExemplar Genetics compliance and trust
Trust signalCompliance2 records
Exemplar Genetics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Exemplar Genetics leadership team
Management profileNumber of profiles
Profiles1 record
Exemplar Genetics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Exemplar Genetics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Exemplar Genetics
What does Exemplar Genetics do?
Exemplar Genetics develops and supplies gene-edited minipig models of human disease for preclinical research. It sells 20 off-the-shelf standard disease models and provides end-to-end custom model development, plus supporting services in characterization, biosecure housing, and preclinical testing (dosing, imaging, functional analysis) to pharmaceutical, biotech, academic, and foundation customers.
Is Exemplar Genetics a public or private company?
Exemplar Genetics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Exemplar Genetics founded?
Exemplar Genetics was founded in 2007. It employs 11 to 50 people.
Where is Exemplar Genetics based?
Exemplar Genetics is headquartered in Sioux Center, United States, in the North America region.
How does Exemplar Genetics make money?
Five revenue lines are on record. Standard Minipig Models are the primary driver. The others are custom Model Development, characterization Services, housing Services and preclinical Services.
Who are Exemplar Genetics's main competitors?
Emerging players on record are Ozgene and Hera BioLabs. Broad incumbents are Inotiv, Charles River Laboratories, Labcorp (Covance) and The Jackson Laboratory. Direct peers are Cyagen Biosciences, Taconic Biosciences, Sinclair Research and Marshall BioResources.
Does Exemplar Genetics have an API?
No public API is recorded for Exemplar Genetics.
What industry is Exemplar Genetics in?
Exemplar Genetics's product category is Preclinical Translational Disease Models. Its primary akta.pro industry code is HLAIALAC, Preclinical Development (Pharmacology, PK/PD, ADME, Toxicology). Its NAICS code is 541714 and its SIC code is 8731.